Cited by 145Bariatric Surgery and OutcomesVagus Nerve Stimulation ResearchPharmacology and Obesity Treatment

Two-Year Outcomes of Vagal Nerve Blocking (vBloc) for the Treatment of Obesity in the ReCharge Trial

Open access
Apovian, Caroline M., Shah, Sajani N., Wolfe, Bruce M., Ikramuddin, Sayeed, Miller, Christopher J., Tweden, Katherine S., Billington, Charles J., Shikora, Scott A.·2017·Obesity Surgery

Abstract

BACKGROUND: The ReCharge Trial demonstrated that a vagal blocking device (vBloc) is a safe and effective treatment for moderate to severe obesity. This report summarizes 24-month outcomes. METHODS: with at least one comorbid condition were randomized to either vBloc therapy or sham intervention for 12 months. After 12 months, participants randomized to vBloc continued open-label vBloc therapy and are the focus of this report. Weight loss, adverse events, comorbid risk factors, and quality of life (QOL) will be assessed for 5 years. RESULTS: At 24 months, 123 (76 %) vBloc participants remained in the trial. Participants who presented at 24 months (n = 103) had a mean excess weight loss (EWL) of 21 % (8 % total weight loss [TWL]); 58 % of participants had ≥5 % TWL and 34 % had ≥10 % TWL. Among the subset of participants with abnormal preoperative values, significant improvements were observed in mean LDL (-16 mg/dL) and HDL cholesterol (+4 mg/dL), triglycerides (-46 mg/dL), HbA1c (-0.3 %), and systolic (-11 mmHg) and diastolic blood pressures (-10 mmHg). QOL measures were significantly improved. Heartburn/dyspepsia and implant site pain were the most frequently reported adverse events. The primary related serious adverse event rate was 4.3 %. CONCLUSIONS: vBloc therapy continues to result in medically meaningful weight loss with a favorable safety profile through 2 years. TRIAL REGISTRATION: https://clinicaltrials.gov/ct2/show/NCT01327976.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s11695-016-2325-7

Cites

14 of 14 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. [13]Schauer PR Bhatt DL Kirwin JP Wolski K Brethauer SA Navaneethan SD Bariatric surgery versus intensive medical therapy in obese patients with diabetes—3-year outcomes NEJM 2014 PMC3372918 22449319

Cited by

Sorted by citations

Authors
Apovian, C. M., Shah, S. N., Wolfe, B. M., Ikramuddin, S., Miller, C. J., Tweden, K. S., Billington, C. J., & Shikora, S. A.
Affiliations
  • Boston University (US)
  • Tufts Medical Center (US)
  • Oregon Health & Science University (US)
  • University of Minnesota (US)
  • ReShape Lifesciences (United States) (US)
  • Brigham and Women's Hospital (US)
Corresponding author
Tweden, Katherine S.
Venue
Obesity Surgery
Published
2016-08-10
Volume
27
Issue
1
Pages
169-176
ISSN
  • 0960-8923 (ISSN-L)
  • 1708-0428
OpenAlex
W2513083063
Cited by
145
References
14
Citations by year
2026: 8 · 2025: 14 · 2024: 12 · 2023: 13 · 2022: 12 · 2021: 20 · 2020: 20 · 2019: 20 · 2018: 17 · 2017: 6 · 2016: 2 · 2015: 1
FWCI
16.62
Type
journal article
Language
en
Open access
Locations
  • Obesity Surgery (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Surgery › Bariatric Surgery and Outcomes
  • Life Sciences › Neuroscience › Neurology › Vagus Nerve Stimulation Research
  • Health Sciences › Medicine › Pharmacology › Pharmacology and Obesity Treatment
MeSH terms
Adult, Autonomic Nerve Block, Double-Blind Method, Electrodes, Implanted, Electric Stimulation Therapy, Female, Follow-Up Studies, Humans, Male, Middle Aged, Obesity, Morbid, Quality of Life, Risk Factors, Vagus Nerve, Weight Loss, Treatment Outcome, Cross-Over Studies, Vagus Nerve Stimulation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review